Phase 2 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 60 years old
- You have been diagnosed with rheumatoid arthritis (a condition where the immune system attacks the joints) for at least 6 months, based on recognized medical guidelines
- You have been taking one or more standard arthritis medications (called DMARDs) for at least 6 months, with your dose staying the same for at least 1 month before the study starts
- Your rheumatoid arthritis is still active and not fully controlled, even while taking your current arthritis medications (confirm with trial site)
- You, or your legal representative, are willing and able to sign a consent form agreeing to take part
Who may not be able to join:
- You are currently pregnant or breastfeeding
- You have liver problems, where certain liver-related blood test results are higher than 1.5 times the normal level
- You have kidney problems, shown by a specific blood test result being above a certain level (confirm with trial site)
- You currently have an active infection or any form of cancer
- You have other medical conditions that are not well controlled, or you have another rheumatic disease (a disease affecting joints or connective tissue)
- You are currently taking a blood-thinning medication called warfarin, or other drugs that may interact with a supplement called carnitine (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +2001223360548
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
change in DAS28 ESR for both arms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.